Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. Article uri icon

Overview

publication date

  • December 15, 2018

Research

keywords

  • Anti-HIV Agents
  • Genitalia
  • HIV Infections
  • HIV-1
  • Heterocyclic Compounds, 3-Ring
  • Lamivudine
  • Virus Shedding

Identity

PubMed Central ID

  • PMC6231952

Scopus Document Identifier

  • 85056322586

Digital Object Identifier (DOI)

  • 10.1097/QAI.0000000000001863

PubMed ID

  • 30383591

Additional Document Info

volume

  • 79

issue

  • 5